Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

We evaluated the impact of achieving a rapid response in 840 newly diagnosed multiple myeloma patients from 2004 to 2015. Rates of very good partial response (VGPR) or better were 29% (240/840) after 2 cycles of treatment, 42% (350/840) after 4 cycles of treatment, and 66% (552/840) as best response...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Blood Adv
Główni autorzy: Tandon, Nidhi, Sidana, Surbhi, Rajkumar, S. Vincent, Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Gonsalves, Wilson I., Dispenzieri, Angela, Kourelis, Taxiarchis V., Warsame, Rahma, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Hwa, Yi Lisa, Kyle, Robert A., Leung, Nelson, Go, Ronald S., Lust, John A., Russell, Stephen J., Kumar, Shaji K.
Format: Artigo
Język:Inglês
Wydane: American Society of Hematology 2019
Hasła przedmiotowe:
Lymphoid Neoplasia
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6418495/
https://ncbi.nlm.nih.gov/pubmed/30824418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018022806
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy